Overview
- It generally takes 2-3 days for CVD patients to get their biochemical examination reports. This long wait tends to cause not only a waste in medical resources but also a delay in getting proper attention.
- Combining optical waveguide-based materials with particle plasmon resonance technology, this optical fiber biosensor has the capacity for rapid testing, high sensitivity, reliability, and specificity, and label-free detection.
- Help physicians make more personalized therapeutic and management decisions, thereby improving clinical efficacy.
Development Process
Over the course of this project under the Applied Research Incubation Program, the team completed the following: a dual-channel engineering prototype, safety testing, clinical trials, patent and market analysis, and business plan writing. On August 9, 2016, Instant NanoBiosensors Co., Ltd. was established.
